Bank of America reiterated their neutral rating on shares of Humana (NYSE:HUM – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. Bank of America currently has a $342.00 price objective on the insurance provider’s stock, down from their previous price objective of $470.00. A number of other research analysts also recently […]